Impact Of Rising Alcohol Consumption On Market Growth: The Driving Engine Behind Liver Disease Diagnostics Market Evolution in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Liver Disease Diagnostics Market Size Growth Forecast: What to Expect by 2025?
The valuation of the liver disease diagnostics sector has experienced robust expansion recently, projected to ascend from $36.26 billion in 2024 to reach $38.95 billion by 2025, reflecting a compounded annual growth rate of 7.4%. This upward trajectory throughout the past period is fundamentally driven by several factors, including the escalating incidence of liver ailments, both sudden and long-term, the widespread increase in liver-related pathologies, greater intake of alcoholic beverages, heightened public understanding of liver wellness, and the continuous development of medical care facilities.

How Will the Liver Disease Diagnostics Market Size Evolve and Grow by 2029?
Anticipated for robust expansion, the domain concerned with diagnosing liver ailments is projected to reach a valuation of $51.62 billion by the year 2029, exhibiting a consistent annual growth rate (CAGR) of 7.3% throughout the forecast horizon. This upward trajectory is fueled by several factors, notably the swelling numbers of elderly individuals, augmented expenditure on research and development initiatives, a greater frequency of both disease occurrences and necessary biopsy procedures, alongside the wider uptake of remote healthcare solutions. Over this same timeframe, key transformative currents shaping the market involve the increasing prominence of individualized medical treatments, ongoing progress in the creation of diagnostic kits, enhancements to rapid testing capabilities, general technological leaps within the healthcare industry, and sophisticated evolution in diagnostic techniques themselves.

View the full report here:
https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

What Drivers Are Propelling the Growth of Liver Disease Diagnostics Market Forward?
The subsequent expansion of the liver disease diagnostics sector is anticipated to be fueled by a rise in the intake of alcoholic beverages. This heightened consumption is attributed to evolving societal behaviors, enhanced accessibility, broader distribution channels, and escalating levels of tension or psychological distress. Diagnostic tools for liver conditions hold substantial importance in tracking how alcohol use affects hepatic wellness, facilitating the identification of initial indicators of liver impairment, like steatosis, inflammation, or cirrhosis. To illustrate this trend, data from December 2022, referenced by the National Health Service, a governmental body situated in England, indicated that the proportion of the populace reporting alcohol consumption within the preceding year climbed proportionally with age groups, beginning at 62% for 16-to-24-year-olds and peaking at 85% for those spanning 55 to 74 years of age; consequently, this upward trend in alcohol consumption serves as a catalyst for the progression of the liver disease diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Which Emerging Trends Are Transforming the Liver Disease Diagnostics Market in 2025?
Pioneering firms within the liver ailment diagnostics sector are concentrating efforts on devising novel approaches, specifically non-surgical techniques for liver evaluation, intending to forge diagnostic pathways that are both more precise and effective. A liver assessment method categorized as non-invasive pertains to diagnostic procedures that gauge the state of the liver through modalities such as imaging techniques like elastography or biochemical assays from blood samples, thereby circumventing the necessity for intrusive interventions such as tissue sampling. To illustrate this, in the month of September in 2024, City Imaging & Clinical, a diagnostic establishment headquartered in India, introduced FibroScan, which functions as a non-invasive instrument for appraising the liver, designed to facilitate the early identification of hepatic conditions like non-alcoholic fatty liver disease and alcohol-related liver disease. This sophisticated apparatus permits swift and precise quantification of hepatic stiffness and lipid accumulation without requiring invasive actions like biopsies. The entire process is brief, generally concluding within a timeframe of five to fifteen minutes, and entails applying a sensor directly onto the skin located above the liver area. This sensor generates auditory waves that serve to quantify the rigidity of the liver tissue, aiding in the determination of the extent of scar formation or fibrosis present.

What Are the Key Segments in the Liver Disease Diagnostics Market?
The liver disease diagnosticsmarket covered in this report is segmented -

1) By Diagnosis Technique: Laboratory Tests; Imaging; Endoscopy; Biopsy; Other Diagnosis Techniques
2) By Disease: Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Steatohepatitis; Fibrosis; Cirrhosis; Hepatocellular Carcinoma; Other Diseases
3) By End Users: Hospitals; Laboratories; Other End Users

Subsegments:
1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel); Enzyme Tests (ALT, AST, ALP); Genetic Testing; Serological Tests
2) By Imaging: Ultrasound Imaging; CT Scans; MRI; Elastography (FibroScan)
3) By Endoscopy: Esophagogastroduodenoscopy (EGD); Capsule Endoscopy
4) By Biopsy: Liver Biopsy (Needle Biopsy); Fine Needle Aspiration Biopsy; Laparoscopic Biopsy
5) By Other Diagnosis Techniques: Molecular Imaging; Biomarker Testing; Fibrosis Scoring Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

Who Are the Key Players Shaping the Liver Disease Diagnostics Market's Competitive Landscape?
Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

What Geographic Markets Are Powering Growth in the Liver Disease Diagnostics Market?
North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.